Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Interventional × Base Sequence × Clear all

Phase

Status

Completed 4 Terminated 2 Withdrawn 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

pembrolizumab 368 Carboplatin 264 Cyclophosphamide 255 Nivolumab 248 Paclitaxel 209 Cisplatin 201 Specimen Handling 196 Magnetic Resonance Spectroscopy 195 Radiotherapy 177 Dexamethasone 156 Gemcitabine 151 durvalumab 147 Biopsy 139 atezolizumab 131 Lenalidomide 121 Rituximab 116 Doxorubicin 115 Docetaxel 113 Bevacizumab 112 Ipilimumab 107 Radiosurgery 98 Radiation 98 Oxaliplatin 98 Capecitabine 98 fludarabine 95 Fluorouracil 94 Etoposide 94 venetoclax 93 Prednisone 92 Pemetrexed 88

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡